4^th International Congress on Viral Hepatitis June 18-30, -0001 Dublin, Ireland

Track 1: Hepatitis B

Hepatitis B is a liver infection caused by the Hepatitis B virus (HBV). HBV is transmitted through activities that involve percutaneous or mucosal contact with infectious blood or body fluids. HBV can survive outside the body at least 7 days and still be capable of causing infection. The best way to prevent hepatitis B is by getting the hepatitis B vaccine. The pathogenesis and clinical manifestations of hepatitis B are due to the interaction of the virus and the host immune system, which lead to liver injury and potentially cirrhosis and hepatocellular carcinoma. Patients can have either an acute symptomatic disease or an asymptomatic disease.

Related: Hepatitis Conferences | Liver Conferences | Gastroenterology Conferences 2018

12^th Euro-Global Gastroenterology Conferences, September 11-12, 2017 Paris, France; 2^nd Medical Imaging Conferences, September 11-12, 2017, Paris, France; 2^nd International Pancreatic Disorders, September 13-14, 2017, Dallas, USA; 13^th International Clinical Gastroenterology Conferences, November 13-14, 2017, Las Vegas, USA; 10^th International  Gastroenterology Conferences, November 13-14, 2017, Las Vegas, USA; 2^nd International  Digestive Diseases Conferences, December 07-08, 2017, Madrid, Spain; 12^th Global Gastroenterologists Meeting, March 19-20, 2018 Barcelona, Spain; 6^th World Hepatitis Conferences, June 18-20, 2018, Dublin, Ireland; 6^th World Liver Diseases Conferences, June 18-20, 2018, Dublin, Ireland; 12^th International Abdominal Imaging Conferences, June 28-29, 2018, Amsterdam, Netherlands; 12^th International Endoscopy Conferences, June 28-29, 2018, Amsterdam, Netherlands; 6^th International  Hepatology Conferences, May 28-29, 2018, Osaka, Japan; 3^rd International Pancreatic Cancer Conferences, June 11-13, 2018, Rome, Italy; 13^th  International Clinical Gastroenterology Conferences, December 07-08, 2017, Madrid, Spain; 13^th International Hepatology Conferences, December 07-08, 2017, Madrid, Spain; 3^rd International Colorectal Cancer Conferences, February 26-27, 2018, Paris, France; 8^th International Hepatology Conferences, July 5-7, 2018, Vienna, Austria;14^th International Gastroenterology Education Conferences, August 02-04, 2018, Barcelona, Spain; 13^th Pediatric Gastroenterology Conferences, August 02-04, 2018, Barcelona, Spain; The AASLD Liver Meetings, October 20-14, 2017, Washington DC, USA; Stockholm Liver Conferences 2018, February 6-9, 2018, Stockholm, Sweden; Canadian Digestive Diseases Conferences, February 9-12, 2018, Toronto, Canada; The 27th Asian Pacific Association for the Study of the Liver Meetings, March 14 to 18, 2018, New Delhi, India; The International Liver Meetings, April 11-15, 2018, Paris, France; 13th IHPBA World Conferences, September 3-7, 2018 Geneva, Switzerland

Related Associations:

USA and Canada:

Hepatitis B Foundation; Hepatitis Foundation International; American Liver Foundation; Canadian Association of Gastroenterology; Canadian Association for the Study of the Liver; American Association for the Study of Liver Diseases

European Union and UK:

European Association for the Study of the Liver; British Society of Gastroenterology; British Association for the Study of the Liver; Euroliver Foundation; The European Liver and Intestine Transplant Association; The European Society for Paediatric Gastroenterology Hepatology and Nutrition

Asia-Pacific and Middle East:

Asian Pacific Association for the Study of the Liver; Gastroenterological Society of Australia; The Asia-Pacific Primary Liver Cancer Expert Association; The Asian Pacific Association of Gastroenterology; International Society for Digestive Surgery

Track 2: Hepatitis C

Hepatitis C is a devastating viral disease that generally progresses slowly, meaning patients often remain asymptomatic and unaware they are infected until very serious and often expensive complications emerge as a result of damage to the liver. It is estimated that about half of those infected are not aware that they carry the virus. The recent remarkable advances in treating hepatitis C built on incremental improvements achieved over the previous two decades to transform hepatitis C from a chronic, fatal disease, to an infection that with new and forthcoming treatments, can be potentially cured.

Related: Hepatitis Conferences | Liver Conferences | Gastroenterology Conferences 2018

12^th Euro-Global Gastroenterology Conferences, September 11-12, 2017 Paris, France; 2^nd Medical Imaging Conferences, September 11-12, 2017, Paris, France; 2^nd International Pancreatic Disorders, September 13-14, 2017, Dallas, USA; 13^th International Clinical Gastroenterology Conferences, November 13-14, 2017, Las Vegas, USA; 10^th International  Gastroenterology Conferences, November 13-14, 2017, Las Vegas, USA; 2^nd International  Digestive Diseases Conferences, December 07-08, 2017, Madrid, Spain; 12^th Global Gastroenterologists Meeting, March 19-20, 2018 Barcelona, Spain; 6^th World Hepatitis Conferences, June 18-20, 2018, Dublin, Ireland; 6^th World Liver Diseases Conferences, June 18-20, 2018, Dublin, Ireland; 12^th International Abdominal Imaging Conferences, June 28-29, 2018, Amsterdam, Netherlands; 12^th International Endoscopy Conferences, June 28-29, 2018, Amsterdam, Netherlands; 6^th International  Hepatology Conferences, May 28-29, 2018, Osaka, Japan; 3^rd International Pancreatic Cancer Conferences, June 11-13, 2018, Rome, Italy; 13^th  International Clinical Gastroenterology Conferences, December 07-08, 2017, Madrid, Spain; 13^th International Hepatology Conferences, December 07-08, 2017, Madrid, Spain; 3^rd International Colorectal Cancer Conferences, February 26-27, 2018, Paris, France; 8^th International Hepatology Conferences, July 5-7, 2018, Vienna, Austria;14^th International Gastroenterology Education Conferences, August 02-04, 2018, Barcelona, Spain; 13^th Pediatric Gastroenterology Conferences, August 02-04, 2018, Barcelona, Spain; The AASLD Liver Meetings, October 20-14, 2017, Washington DC, USA; Stockholm Liver Conferences 2018, February 6-9, 2018, Stockholm, Sweden; Canadian Digestive Diseases Conferences, February 9-12, 2018, Toronto, Canada; The 27th Asian Pacific Association for the Study of the Liver Meetings, March 14 to 18, 2018, New Delhi, India; The International Liver Meetings, April 11-15, 2018, Paris, France; 13th IHPBA World Conferences, September 3-7, 2018 Geneva, Switzerland

Related Associations:

USA and Canada:

American Hepato-Pancreato-Biliary Association; Canadian Liver Foundation; International Association for the Study of the Liver; International Hepato Pancreato Biliary Association; American Association for the Study of Liver Diseases

European Union and UK:

European Association for the Study of the Liver; Children's Liver Disease Foundation; International Liver Transplantation Society; The European Society for Paediatric Gastroenterology Hepatology and Nutrition

Asia-Pacific and Middle East:

 The Asia-Pacific Primary Liver Cancer Expert Association; The Asian Pacific Association of Gastroenterology; Asian Pacific Association for the Study of the Liver; International Society for Digestive Surgery

Track 3: Hepatitis A, D & E

Hepatitis A is an acute infection of the liver caused by the hepatitis A virus. Vaccination against hepatitis A is available. Hepatitis D is a liver disease caused by the hepatitis D virus, (also called delta virus) a defective virus that needs the hepatitis B virus to exist. Infection with hepatitis D can be prevented by hepatitis B vaccine. Hepatitis E is an acute illness but does not cause a chronic infection. It is transmitted via the faecal-oral route and can be spread by eating or drinking contaminated food or water.

Related: Hepatitis Conferences | Liver Conferences | Gastroenterology Conferences 2018

12^th Euro-Global Gastroenterology Conferences, September 11-12, 2017 Paris, France; 2^nd Medical Imaging Conferences, September 11-12, 2017, Paris, France; 2^nd International Pancreatic Disorders, September 13-14, 2017, Dallas, USA; 13^th International Clinical Gastroenterology Conferences, November 13-14, 2017, Las Vegas, USA; 10^th International  Gastroenterology Conferences, November 13-14, 2017, Las Vegas, USA; 2^nd International  Digestive Diseases Conferences, December 07-08, 2017, Madrid, Spain; 12^th Global Gastroenterologists Meeting, March 19-20, 2018 Barcelona, Spain; 6^th World Hepatitis Conferences, June 18-20, 2018, Dublin, Ireland; 6^th World Liver Diseases Conferences, June 18-20, 2018, Dublin, Ireland; 12^th International Abdominal Imaging Conferences, June 28-29, 2018, Amsterdam, Netherlands; 12^th International Endoscopy Conferences, June 28-29, 2018, Amsterdam, Netherlands; 6^th International  Hepatology Conferences, May 28-29, 2018, Osaka, Japan; 3^rd International Pancreatic Cancer Conferences, June 11-13, 2018, Rome, Italy; 13^th  International Clinical Gastroenterology Conferences, December 07-08, 2017, Madrid, Spain; 13^th International Hepatology Conferences, December 07-08, 2017, Madrid, Spain; 3^rd International Colorectal Cancer Conferences, February 26-27, 2018, Paris, France; 8^th International Hepatology Conferences, July 5-7, 2018, Vienna, Austria;14^th International Gastroenterology Education Conferences, August 02-04, 2018, Barcelona, Spain; 13^th Pediatric Gastroenterology Conferences, August 02-04, 2018, Barcelona, Spain; The AASLD Liver Meetings, October 20-14, 2017, Washington DC, USA; Stockholm Liver Conferences 2018, February 6-9, 2018, Stockholm, Sweden; Canadian Digestive Diseases Conferences, February 9-12, 2018, Toronto, Canada; The 27th Asian Pacific Association for the Study of the Liver Meetings, March 14 to 18, 2018, New Delhi, India; The International Liver Meetings, April 11-15, 2018, Paris, France; 13th IHPBA World Conferences, September 3-7, 2018 Geneva, Switzerland

Related Associations:

USA and Canada:

American Association for the Study of Liver Diseases;  American Liver Foundation; Canadian Association of Gastroenterology; Canadian Association for the Study of the Liver; Hepatitis B Foundation; Hepatitis Foundation International

European Union and UK:

British Society of Gastroenterology; British Association for the Study of the Liver; Euroliver Foundation; The European Liver and Intestine Transplant Association; The Belgian Association for the Study of the Liver

Asia-Pacific and Middle East:

Gastroenterological Society of Australia; International Society for Digestive Surgery; Taiwan Liver Cancer Association; The Korean Association for the Study of the Liver

Track 4: Hepatitis Vaccination

The best way to prevent hepatitis is by getting the hepatitis vaccines. Vaccination is safe and effective and it is recommended for all. Efforts to develop a hepatitis C vaccine started more than 20 years ago, when the hepatitis C virus was identified. The hepatitis C virus is more variable than are the viruses that cause hepatitis A and hepatitis B. Hepatitis C virus occurs in at least six genetically distinct forms with 50 subtypes. A global vaccine would have to protect against all these variants of the virus.

Related: Hepatitis Conferences | Liver Conferences | Gastroenterology Conferences 2018

12^th Euro-Global Gastroenterology Conferences, September 11-12, 2017 Paris, France; 2^nd Medical Imaging Conferences, September 11-12, 2017, Paris, France; 2^nd International Pancreatic Disorders, September 13-14, 2017, Dallas, USA; 13^th International Clinical Gastroenterology Conferences, November 13-14, 2017, Las Vegas, USA; 10^th International  Gastroenterology Conferences, November 13-14, 2017, Las Vegas, USA; 2^nd International  Digestive Diseases Conferences, December 07-08, 2017, Madrid, Spain; 12^th Global Gastroenterologists Meeting, March 19-20, 2018 Barcelona, Spain; 6^th World Hepatitis Conferences, June 18-20, 2018, Dublin, Ireland; 6^th World Liver Diseases Conferences, June 18-20, 2018, Dublin, Ireland; 12^th International Abdominal Imaging Conferences, June 28-29, 2018, Amsterdam, Netherlands; 12^th International Endoscopy Conferences, June 28-29, 2018, Amsterdam, Netherlands; 6^th International  Hepatology Conferences, May 28-29, 2018, Osaka, Japan; 3^rd International Pancreatic Cancer Conferences, June 11-13, 2018, Rome, Italy; 13^th  International Clinical Gastroenterology Conferences, December 07-08, 2017, Madrid, Spain; 13^th International Hepatology Conferences, December 07-08, 2017, Madrid, Spain; 3^rd International Colorectal Cancer Conferences, February 26-27, 2018, Paris, France; 8^th International Hepatology Conferences, July 5-7, 2018, Vienna, Austria;14^th International Gastroenterology Education Conferences, August 02-04, 2018, Barcelona, Spain; 13^th Pediatric Gastroenterology Conferences, August 02-04, 2018, Barcelona, Spain; The AASLD Liver Meetings, October 20-14, 2017, Washington DC, USA; Stockholm Liver Conferences 2018, February 6-9, 2018, Stockholm, Sweden; Canadian Digestive Diseases Conferences, February 9-12, 2018, Toronto, Canada; The 27th Asian Pacific Association for the Study of the Liver Meetings, March 14 to 18, 2018, New Delhi, India; The International Liver Meetings, April 11-15, 2018, Paris, France; 13th IHPBA World Conferences, September 3-7, 2018 Geneva, Switzerland

Related Associations:

USA and Canada:

American Hepato-Pancreato-Biliary Association; Canadian Liver Foundation; International Association for the Study of the Liver; International Hepato Pancreato Biliary Association

European Union and UK:

Children's Liver Disease Foundation; International Liver Transplantation Society; The Belgian Association for the Study of the Liver; European Association for the Study of the Liver

Asia-Pacific

Taiwan Liver Cancer Association; The Korean Association for the Study of the Liver; The Asia-Pacific Primary Liver Cancer Expert Association; The Asian Pacific Association of Gastroenterology

Track 5: Hepatitis Clinical Research trials

The aim of the clinical research studies is to learn more about the hepatitis C virus, how it replicates, what causes the damage to the liver and what role the immune system plays in the disease. Research in Hepatitis is becoming increasingly important as millions of people are afflicted with hepatitis each year.

Related: Hepatitis Conferences | Liver Conferences | Gastroenterology Conferences 2018

12^th Euro-Global Gastroenterology Conferences, September 11-12, 2017 Paris, France; 2^nd Medical Imaging Conferences, September 11-12, 2017, Paris, France; 2^nd International Pancreatic Disorders, September 13-14, 2017, Dallas, USA; 13^th International Clinical Gastroenterology Conferences, November 13-14, 2017, Las Vegas, USA; 10^th International  Gastroenterology Conferences, November 13-14, 2017, Las Vegas, USA; 2^nd International  Digestive Diseases Conferences, December 07-08, 2017, Madrid, Spain; 12^th Global Gastroenterologists Meeting, March 19-20, 2018 Barcelona, Spain; 6^th World Hepatitis Conferences, June 18-20, 2018, Dublin, Ireland; 6^th World Liver Diseases Conferences, June 18-20, 2018, Dublin, Ireland; 12^th International Abdominal Imaging Conferences, June 28-29, 2018, Amsterdam, Netherlands; 12^th International Endoscopy Conferences, June 28-29, 2018, Amsterdam, Netherlands; 6^th International  Hepatology Conferences, May 28-29, 2018, Osaka, Japan; 3^rd International Pancreatic Cancer Conferences, June 11-13, 2018, Rome, Italy; 13^th  International Clinical Gastroenterology Conferences, December 07-08, 2017, Madrid, Spain; 13^th International Hepatology Conferences, December 07-08, 2017, Madrid, Spain; 3^rd International Colorectal Cancer Conferences, February 26-27, 2018, Paris, France; 8^th International Hepatology Conferences, July 5-7, 2018, Vienna, Austria;14^th International Gastroenterology Education Conferences, August 02-04, 2018, Barcelona, Spain; 13^th Pediatric Gastroenterology Conferences, August 02-04, 2018, Barcelona, Spain; The AASLD Liver Meetings, October 20-14, 2017, Washington DC, USA; Stockholm Liver Conferences 2018, February 6-9, 2018, Stockholm, Sweden; Canadian Digestive Diseases Conferences, February 9-12, 2018, Toronto, Canada; The 27th Asian Pacific Association for the Study of the Liver Meetings, March 14 to 18, 2018, New Delhi, India; The International Liver Meetings, April 11-15, 2018, Paris, France; 13th IHPBA World Conferences, September 3-7, 2018 Geneva, Switzerland

Related Associations:

USA and Canada:

American Hepato-Pancreato-Biliary Association; Canadian Liver Foundation; International Association for the Study of the Liver; International Hepato Pancreato Biliary Association

European Union and UK:

European Association for the Study of the Liver; Children's Liver Disease Foundation; International Liver Transplantation Society; The European Society for Paediatric Gastroenterology Hepatology and Nutrition

Asia-Pacific and Middle East:

The Asia-Pacific Primary Liver Cancer Expert Association; The Asian Pacific Association of Gastroenterology; The Korean Association for the Study of the Liver; Asian Pacific Association for the Study of the Liver

Track 6: Non-viral Hepatitis

Non-viral hepatitis is an inflammation of the liver caused by toxins, drugs, or other harmful chemicals that destroy cells in the liver (Hepatocytes).  Acute hepatitis damages hepatocytes, make up 70-85% of the total mass of the liver. The disease is a growing problem due to the increasing number of dietary supplements with liver side effects. If hepatitis leads to liver failure, a liver transplant is the only treatment option that can improve survival.

Related: Hepatitis Conferences | Liver Conferences | Gastroenterology Conferences 2018

12^th Euro-Global Gastroenterology Conferences, September 11-12, 2017 Paris, France; 2^nd Medical Imaging Conferences, September 11-12, 2017, Paris, France; 2^nd International Pancreatic Disorders, September 13-14, 2017, Dallas, USA; 13^th International Clinical Gastroenterology Conferences, November 13-14, 2017, Las Vegas, USA; 10^th International  Gastroenterology Conferences, November 13-14, 2017, Las Vegas, USA; 2^nd International  Digestive Diseases Conferences, December 07-08, 2017, Madrid, Spain; 12^th Global Gastroenterologists Meeting, March 19-20, 2018 Barcelona, Spain; 6^th World Hepatitis Conferences, June 18-20, 2018, Dublin, Ireland; 6^th World Liver Diseases Conferences, June 18-20, 2018, Dublin, Ireland; 12^th International Abdominal Imaging Conferences, June 28-29, 2018, Amsterdam, Netherlands; 12^th International Endoscopy Conferences, June 28-29, 2018, Amsterdam, Netherlands; 6^th International  Hepatology Conferences, May 28-29, 2018, Osaka, Japan; 3^rd International Pancreatic Cancer Conferences, June 11-13, 2018, Rome, Italy; 13^th  International Clinical Gastroenterology Conferences, December 07-08, 2017, Madrid, Spain; 13^th International Hepatology Conferences, December 07-08, 2017, Madrid, Spain; 3^rd International Colorectal Cancer Conferences, February 26-27, 2018, Paris, France; 8^th International Hepatology Conferences, July 5-7, 2018, Vienna, Austria;14^th International Gastroenterology Education Conferences, August 02-04, 2018, Barcelona, Spain; 13^th Pediatric Gastroenterology Conferences, August 02-04, 2018, Barcelona, Spain; The AASLD Liver Meetings, October 20-14, 2017, Washington DC, USA; Stockholm Liver Conferences 2018, February 6-9, 2018, Stockholm, Sweden; Canadian Digestive Diseases Conferences, February 9-12, 2018, Toronto, Canada; The 27th Asian Pacific Association for the Study of the Liver Meetings, March 14 to 18, 2018, New Delhi, India; The International Liver Meetings, April 11-15, 2018, Paris, France; 13th IHPBA World Conferences, September 3-7, 2018 Geneva, Switzerland

Related Associations:

USA and Canada:

American Association for the Study of Liver Diseases;  American Liver Foundation; Canadian Association of Gastroenterology; Canadian Association for the Study of the Liver; Hepatitis B Foundation; Hepatitis Foundation International

European Union and UK:

British Society of Gastroenterology; British Association for the Study of the Liver; Euroliver Foundation; The European Liver and Intestine Transplant Association; The Belgian Association for the Study of the Liver

Asia-Pacific and Middle East:

 Asian Pacific Association for the Study of the Liver; Gastroenterological Society of Australia; The Asian Pacific Association of Gastroenterology; International Society for Digestive Surgery

Track 7: Epidemiology of Hepatitis

Hepatitis virus infection is a global public health problem. The implementation of effective vaccination programs in many countries has resulted in a significant decrease in the incidence of hepatitis. During the acute phase, manifestations range from subclinical or anicteric hepatitis to icteric hepatitis and, in some cases, fulminant hepatitis. During the chronic phase, manifestations range from an asymptomatic carrier state to chronic hepatitis, cirrhosis, and hepatocellular carcinoma.

Related: Hepatitis Conferences | Liver Conferences | Gastroenterology Conferences 2018

12^th Euro-Global Gastroenterology Conferences, September 11-12, 2017 Paris, France; 2^nd Medical Imaging Conferences, September 11-12, 2017, Paris, France; 2^nd International Pancreatic Disorders, September 13-14, 2017, Dallas, USA; 13^th International Clinical Gastroenterology Conferences, November 13-14, 2017, Las Vegas, USA; 10^th International  Gastroenterology Conferences, November 13-14, 2017, Las Vegas, USA; 2^nd International  Digestive Diseases Conferences, December 07-08, 2017, Madrid, Spain; 12^th Global Gastroenterologists Meeting, March 19-20, 2018 Barcelona, Spain; 6^th World Hepatitis Conferences, June 18-20, 2018, Dublin, Ireland; 6^th World Liver Diseases Conferences, June 18-20, 2018, Dublin, Ireland; 12^th International Abdominal Imaging Conferences, June 28-29, 2018, Amsterdam, Netherlands; 12^th International Endoscopy Conferences, June 28-29, 2018, Amsterdam, Netherlands; 6^th International  Hepatology Conferences, May 28-29, 2018, Osaka, Japan; 3^rd International Pancreatic Cancer Conferences, June 11-13, 2018, Rome, Italy; 13^th  International Clinical Gastroenterology Conferences, December 07-08, 2017, Madrid, Spain; 13^th International Hepatology Conferences, December 07-08, 2017, Madrid, Spain; 3^rd International Colorectal Cancer Conferences, February 26-27, 2018, Paris, France; 8^th International Hepatology Conferences, July 5-7, 2018, Vienna, Austria;14^th International Gastroenterology Education Conferences, August 02-04, 2018, Barcelona, Spain; 13^th Pediatric Gastroenterology Conferences, August 02-04, 2018, Barcelona, Spain; The AASLD Liver Meetings, October 20-14, 2017, Washington DC, USA; Stockholm Liver Conferences 2018, February 6-9, 2018, Stockholm, Sweden; Canadian Digestive Diseases Conferences, February 9-12, 2018, Toronto, Canada; The 27th Asian Pacific Association for the Study of the Liver Meetings, March 14 to 18, 2018, New Delhi, India; The International Liver Meetings, April 11-15, 2018, Paris, France; 13th IHPBA World Conferences, September 3-7, 2018 Geneva, Switzerland

Related Associations:

USA and Canada:

American Association for the Study of Liver Diseases; American Liver Foundation; Canadian Association of Gastroenterology; Canadian Association for the Study of the Liver; Hepatitis B Foundation; Hepatitis Foundation International

European Union and UK:

British Society of Gastroenterology; British Association for the Study of the Liver; Euroliver Foundation; The European Liver and Intestine Transplant Association; The Belgian Association for the Study of the Liver

Asia-Pacific and Middle East:

Asian Pacific Association for the Study of the Liver; Gastroenterological Society of Australia; International Society for Digestive Surgery; Taiwan Liver Cancer Association

Track 8: Hepatocellular Carcinoma

Hepatocellular carcinoma accounts for most liver cancers. This type of liver cancer occurs more often in men than women and is usually seen in people age 50 or older. It is commonly associated with cirrhosis and hepatitis. The incidence of hepatocellular carcinoma is highest in Asia and Africa, where the endemic high prevalence of hepatitis B and hepatitis C strongly predisposes to the development of chronic liver disease and subsequent development of hepatocellular carcinoma. Other risk factors can include a history of alcohol abuse.

Related: Hepatitis Conferences | Liver Conferences | Gastroenterology Conferences 2018

12^th Euro-Global Gastroenterology Conferences, September 11-12, 2017 Paris, France; 2^nd Medical Imaging Conferences, September 11-12, 2017, Paris, France; 2^nd International Pancreatic Disorders, September 13-14, 2017, Dallas, USA; 13^th International Clinical Gastroenterology Conferences, November 13-14, 2017, Las Vegas, USA; 10^th International  Gastroenterology Conferences, November 13-14, 2017, Las Vegas, USA; 2^nd International  Digestive Diseases Conferences, December 07-08, 2017, Madrid, Spain; 12^th Global Gastroenterologists Meeting, March 19-20, 2018 Barcelona, Spain; 6^th World Hepatitis Conferences, June 18-20, 2018, Dublin, Ireland; 6^th World Liver Diseases Conferences, June 18-20, 2018, Dublin, Ireland; 12^th International Abdominal Imaging Conferences, June 28-29, 2018, Amsterdam, Netherlands; 12^th International Endoscopy Conferences, June 28-29, 2018, Amsterdam, Netherlands; 6^th International  Hepatology Conferences, May 28-29, 2018, Osaka, Japan; 3^rd International Pancreatic Cancer Conferences, June 11-13, 2018, Rome, Italy; 13^th  International Clinical Gastroenterology Conferences, December 07-08, 2017, Madrid, Spain; 13^th International Hepatology Conferences, December 07-08, 2017, Madrid, Spain; 3^rd International Colorectal Cancer Conferences, February 26-27, 2018, Paris, France; 8^th International Hepatology Conferences, July 5-7, 2018, Vienna, Austria;14^th International Gastroenterology Education Conferences, August 02-04, 2018, Barcelona, Spain; 13^th Pediatric Gastroenterology Conferences, August 02-04, 2018, Barcelona, Spain; The AASLD Liver Meetings, October 20-14, 2017, Washington DC, USA; Stockholm Liver Conferences 2018, February 6-9, 2018, Stockholm, Sweden; Canadian Digestive Diseases Conferences, February 9-12, 2018, Toronto, Canada; The 27th Asian Pacific Association for the Study of the Liver Meetings, March 14 to 18, 2018, New Delhi, India; The International Liver Meetings, April 11-15, 2018, Paris, France; 13th IHPBA World Conferences, September 3-7, 2018 Geneva, Switzerland

Related Associations:

USA and Canada:

American Hepato-Pancreato-Biliary Association; Canadian Liver Foundation; International Association for the Study of the Liver; International Hepato Pancreato Biliary Association

European Union and UK:

European Association for the Study of the Liver; Children's Liver Disease Foundation; International Liver Transplantation Society; The European Society for Paediatric Gastroenterology Hepatology and Nutrition

Asia-Pacific and Middle East:

 The Asia-Pacific Primary Liver Cancer Expert Association; Taiwan Liver Cancer Association; The Korean Association for the Study of the Liver; The Asian Pacific Association of Gastroenterology

Track 9: Liver Diseases

Liver is responsible for many critical functions within the body. It helps your body digest food, store energy, and remove poisons. If it becomes diseased or injured, the loss of those functions can cause significant damage to the body. Producing bile and removing toxins are the important roles played by the liver. There are over 100 different forms of liver disease that affect men, women and children.

Related: Hepatitis Conferences | Liver Conferences | Gastroenterology Conferences 2018

12^th Euro-Global Gastroenterology Conferences, September 11-12, 2017 Paris, France; 2^nd Medical Imaging Conferences, September 11-12, 2017, Paris, France; 2^nd International Pancreatic Disorders, September 13-14, 2017, Dallas, USA; 13^th International Clinical Gastroenterology Conferences, November 13-14, 2017, Las Vegas, USA; 10^th International  Gastroenterology Conferences, November 13-14, 2017, Las Vegas, USA; 2^nd International  Digestive Diseases Conferences, December 07-08, 2017, Madrid, Spain; 12^th Global Gastroenterologists Meeting, March 19-20, 2018 Barcelona, Spain; 6^th World Hepatitis Conferences, June 18-20, 2018, Dublin, Ireland; 6^th World Liver Diseases Conferences, June 18-20, 2018, Dublin, Ireland; 12^th International Abdominal Imaging Conferences, June 28-29, 2018, Amsterdam, Netherlands; 12^th International Endoscopy Conferences, June 28-29, 2018, Amsterdam, Netherlands; 6^th International  Hepatology Conferences, May 28-29, 2018, Osaka, Japan; 3^rd International Pancreatic Cancer Conferences, June 11-13, 2018, Rome, Italy; 13^th  International Clinical Gastroenterology Conferences, December 07-08, 2017, Madrid, Spain; 13^th International Hepatology Conferences, December 07-08, 2017, Madrid, Spain; 3^rd International Colorectal Cancer Conferences, February 26-27, 2018, Paris, France; 8^th International Hepatology Conferences, July 5-7, 2018, Vienna, Austria;14^th International Gastroenterology Education Conferences, August 02-04, 2018, Barcelona, Spain; 13^th Pediatric Gastroenterology Conferences, August 02-04, 2018, Barcelona, Spain; The AASLD Liver Meetings, October 20-14, 2017, Washington DC, USA; Stockholm Liver Conferences 2018, February 6-9, 2018, Stockholm, Sweden; Canadian Digestive Diseases Conferences, February 9-12, 2018, Toronto, Canada; The 27th Asian Pacific Association for the Study of the Liver Meetings, March 14 to 18, 2018, New Delhi, India; The International Liver Meetings, April 11-15, 2018, Paris, France; 13th IHPBA World Conferences, September 3-7, 2018 Geneva, Switzerland

Related Associations:

USA and Canada:

American Association for the Study of Liver Diseases; American Liver Foundation; Canadian Association of Gastroenterology; Canadian Association for the Study of the Liver; Hepatitis B Foundation; Hepatitis Foundation International

European Union and UK:

British Society of Gastroenterology; British Association for the Study of the Liver; Euroliver Foundation; The European Liver and Intestine Transplant Association; The Belgian Association for the Study of the Liver

Asia-Pacific and Middle East:

Asian Pacific Association for the Study of the Liver; Gastroenterological Society of Australia; International Society for Digestive Surgery; Taiwan Liver Cancer Association

Track 10: Metabolic Liver Diseases

The metabolic liver diseases in adults include and iron overload (hemochromatosis), Wilson disease and alpha 1-antitrypsin deficiency. The main symptoms of liver imbalance include weakness and fatigue, weight loss, nausea, vomiting, and yellow discoloration of the skin (jaundice).

Related: Hepatitis Conferences | Liver Conferences | Gastroenterology Conferences 2018

12^th Euro-Global Gastroenterology Conferences, September 11-12, 2017 Paris, France; 2^nd Medical Imaging Conferences, September 11-12, 2017, Paris, France; 2^nd International Pancreatic Disorders, September 13-14, 2017, Dallas, USA; 13^th International Clinical Gastroenterology Conferences, November 13-14, 2017, Las Vegas, USA; 10^th International  Gastroenterology Conferences, November 13-14, 2017, Las Vegas, USA; 2^nd International  Digestive Diseases Conferences, December 07-08, 2017, Madrid, Spain; 12^th Global Gastroenterologists Meeting, March 19-20, 2018 Barcelona, Spain; 6^th World Hepatitis Conferences, June 18-20, 2018, Dublin, Ireland; 6^th World Liver Diseases Conferences, June 18-20, 2018, Dublin, Ireland; 12^th International Abdominal Imaging Conferences, June 28-29, 2018, Amsterdam, Netherlands; 12^th International Endoscopy Conferences, June 28-29, 2018, Amsterdam, Netherlands; 6^th International  Hepatology Conferences, May 28-29, 2018, Osaka, Japan; 3^rd International Pancreatic Cancer Conferences, June 11-13, 2018, Rome, Italy; 13^th  International Clinical Gastroenterology Conferences, December 07-08, 2017, Madrid, Spain; 13^th International Hepatology Conferences, December 07-08, 2017, Madrid, Spain; 3^rd International Colorectal Cancer Conferences, February 26-27, 2018, Paris, France; 8^th International Hepatology Conferences, July 5-7, 2018, Vienna, Austria;14^th International Gastroenterology Education Conferences, August 02-04, 2018, Barcelona, Spain; 13^th Pediatric Gastroenterology Conferences, August 02-04, 2018, Barcelona, Spain; The AASLD Liver Meetings, October 20-14, 2017, Washington DC, USA; Stockholm Liver Conferences 2018, February 6-9, 2018, Stockholm, Sweden; Canadian Digestive Diseases Conferences, February 9-12, 2018, Toronto, Canada; The 27th Asian Pacific Association for the Study of the Liver Meetings, March 14 to 18, 2018, New Delhi, India; The International Liver Meetings, April 11-15, 2018, Paris, France; 13th IHPBA World Conferences, September 3-7, 2018 Geneva, Switzerland

Related Associations:

USA and Canada:

American Hepato-Pancreato-Biliary Association; Canadian Liver Foundation; International Association for the Study of the Liver; International Hepato Pancreato Biliary Association

European Union and UK:

European Association for the Study of the Liver; Children's Liver Disease Foundation; International Liver Transplantation Society; The European Society for Paediatric Gastroenterology Hepatology and Nutrition

Asia-Pacific and Middle East:

The Asia-Pacific Primary Liver Cancer Expert Association; The Asian Pacific Association of Gastroenterology; The Korean Association for the Study of the Liver

Track 11: Hepato-Pancreato-Biliary Disease

Hepato-pancreato-biliary disease refers to any condition that affects the liver, pancreas, gallbladder, and the bile ducts. These diseases show common symptoms such as jaundice, darker urine colour, and lighter stool colour.

Related: Hepatitis Conferences | Liver Conferences | Gastroenterology Conferences 2018

12^th Euro-Global Gastroenterology Conferences, September 11-12, 2017 Paris, France; 2^nd Medical Imaging Conferences, September 11-12, 2017, Paris, France; 2^nd International Pancreatic Disorders, September 13-14, 2017, Dallas, USA; 13^th International Clinical Gastroenterology Conferences, November 13-14, 2017, Las Vegas, USA; 10^th International  Gastroenterology Conferences, November 13-14, 2017, Las Vegas, USA; 2^nd International  Digestive Diseases Conferences, December 07-08, 2017, Madrid, Spain; 12^th Global Gastroenterologists Meeting, March 19-20, 2018 Barcelona, Spain; 6^th World Hepatitis Conferences, June 18-20, 2018, Dublin, Ireland; 6^th World Liver Diseases Conferences, June 18-20, 2018, Dublin, Ireland; 12^th International Abdominal Imaging Conferences, June 28-29, 2018, Amsterdam, Netherlands; 12^th International Endoscopy Conferences, June 28-29, 2018, Amsterdam, Netherlands; 6^th International  Hepatology Conferences, May 28-29, 2018, Osaka, Japan; 3^rd International Pancreatic Cancer Conferences, June 11-13, 2018, Rome, Italy; 13^th  International Clinical Gastroenterology Conferences, December 07-08, 2017, Madrid, Spain; 13^th International Hepatology Conferences, December 07-08, 2017, Madrid, Spain; 3^rd International Colorectal Cancer Conferences, February 26-27, 2018, Paris, France; 8^th International Hepatology Conferences, July 5-7, 2018, Vienna, Austria;14^th International Gastroenterology Education Conferences, August 02-04, 2018, Barcelona, Spain; 13^th Pediatric Gastroenterology Conferences, August 02-04, 2018, Barcelona, Spain; The AASLD Liver Meetings, October 20-14, 2017, Washington DC, USA; Stockholm Liver Conferences 2018, February 6-9, 2018, Stockholm, Sweden; Canadian Digestive Diseases Conferences, February 9-12, 2018, Toronto, Canada; The 27th Asian Pacific Association for the Study of the Liver Meetings, March 14 to 18, 2018, New Delhi, India; The International Liver Meetings, April 11-15, 2018, Paris, France; 13th IHPBA World Conferences, September 3-7, 2018 Geneva, Switzerland

Related Associations:

USA and Canada:

Hepatitis B Foundation; Hepatitis Foundation International; American Liver Foundation; Canadian Association of Gastroenterology; Canadian Association for the Study of the Liver; American Association for the Study of Liver Diseases

European Union and UK:

European Association for the Study of the Liver; British Society of Gastroenterology; British Association for the Study of the Liver; Euroliver Foundation; The European Liver and Intestine Transplant Association; The European Society for Paediatric Gastroenterology Hepatology and Nutrition

Asia-Pacific and Middle East:

Asian Pacific Association for the Study of the Liver; Gastroenterological Society of Australia; The Asia-Pacific Primary Liver Cancer Expert Association; The Asian Pacific Association of Gastroenterology; International Society for Digestive Surgery

Track 12: Liver diseases diagnosis

Screening for Liver diseases has been advocated with the intention of intervening to halt its progression. Abnormal liver tests are those that measure synthesis of proteins made by the liver (albumin, clotting factors) or the liver's capacity to metabolize drugs. The impact of diagnosis of hepatitis C virus on quality of life is worse in patients aware of their viral status compared with individuals unaware of their viral status.

Related: Hepatitis Conferences | Liver Conferences | Gastroenterology Conferences 2018

12^th Euro-Global Gastroenterology Conferences, September 11-12, 2017 Paris, France; 2^nd Medical Imaging Conferences, September 11-12, 2017, Paris, France; 2^nd International Pancreatic Disorders, September 13-14, 2017, Dallas, USA; 13^th International Clinical Gastroenterology Conferences, November 13-14, 2017, Las Vegas, USA; 10^th International  Gastroenterology Conferences, November 13-14, 2017, Las Vegas, USA; 2^nd International  Digestive Diseases Conferences, December 07-08, 2017, Madrid, Spain; 12^th Global Gastroenterologists Meeting, March 19-20, 2018 Barcelona, Spain; 6^th World Hepatitis Conferences, June 18-20, 2018, Dublin, Ireland; 6^th World Liver Diseases Conferences, June 18-20, 2018, Dublin, Ireland; 12^th International Abdominal Imaging Conferences, June 28-29, 2018, Amsterdam, Netherlands; 12^th International Endoscopy Conferences, June 28-29, 2018, Amsterdam, Netherlands; 6^th International  Hepatology Conferences, May 28-29, 2018, Osaka, Japan; 3^rd International Pancreatic Cancer Conferences, June 11-13, 2018, Rome, Italy; 13^th  International Clinical Gastroenterology Conferences, December 07-08, 2017, Madrid, Spain; 13^th International Hepatology Conferences, December 07-08, 2017, Madrid, Spain; 3^rd International Colorectal Cancer Conferences, February 26-27, 2018, Paris, France; 8^th International Hepatology Conferences, July 5-7, 2018, Vienna, Austria;14^th International Gastroenterology Education Conferences, August 02-04, 2018, Barcelona, Spain; 13^th Pediatric Gastroenterology Conferences, August 02-04, 2018, Barcelona, Spain; The AASLD Liver Meetings, October 20-14, 2017, Washington DC, USA; Stockholm Liver Conferences 2018, February 6-9, 2018, Stockholm, Sweden; Canadian Digestive Diseases Conferences, February 9-12, 2018, Toronto, Canada; The 27th Asian Pacific Association for the Study of the Liver Meetings, March 14 to 18, 2018, New Delhi, India; The International Liver Meetings, April 11-15, 2018, Paris, France; 13th IHPBA World Conferences, September 3-7, 2018 Geneva, Switzerland

Related Associations:

USA and Canada:

American Association for the Study of Liver Diseases; American Liver Foundation; Canadian Association of Gastroenterology; Canadian Association for the Study of the Liver; Hepatitis B Foundation; Hepatitis Foundation International

European Union and UK:

British Society of Gastroenterology; British Association for the Study of the Liver; Euroliver Foundation; The European Liver and Intestine Transplant Association; The Belgian Association for the Study of the Liver

Asia-Pacific and Middle East:

Asian Pacific Association for the Study of the Liver; Gastroenterological Society of Australia; International Society for Digestive Surgery; Taiwan Liver Cancer Association

Track 13: Liver Transplantation and Surgery

Liver transplantation surgery technique to replace a diseased or injured liver with a healthy liver delivered from a healthy person. The liver is involved in various metabolic functioning including metabolism of drugs and toxins, removing degradation products of normal body metabolism (for example clearance of ammonia and bilirubin from the blood), and synthesis of many important proteins and enzymes (such as factors necessary for blood to clot). Doctors or surgeons suggest liver transplant surgery to the patients who suffer from severe Drug-induced liver injury (DILI) or Chronic liver failure. This surgery carries a risk of other complications including infection, liver inflammation, blood clots, liver rejection, memory and thinking problems.

Related: Hepatitis Conferences | Liver Conferences | Gastroenterology Conferences 2018

12^th Euro-Global Gastroenterology Conferences, September 11-12, 2017 Paris, France; 2^nd Medical Imaging Conferences, September 11-12, 2017, Paris, France; 2^nd International Pancreatic Disorders, September 13-14, 2017, Dallas, USA; 13^th International Clinical Gastroenterology Conferences, November 13-14, 2017, Las Vegas, USA; 10^th International  Gastroenterology Conferences, November 13-14, 2017, Las Vegas, USA; 2^nd International  Digestive Diseases Conferences, December 07-08, 2017, Madrid, Spain; 12^th Global Gastroenterologists Meeting, March 19-20, 2018 Barcelona, Spain; 6^th World Hepatitis Conferences, June 18-20, 2018, Dublin, Ireland; 6^th World Liver Diseases Conferences, June 18-20, 2018, Dublin, Ireland; 12^th International Abdominal Imaging Conferences, June 28-29, 2018, Amsterdam, Netherlands; 12^th International Endoscopy Conferences, June 28-29, 2018, Amsterdam, Netherlands; 6^th International  Hepatology Conferences, May 28-29, 2018, Osaka, Japan; 3^rd International Pancreatic Cancer Conferences, June 11-13, 2018, Rome, Italy; 13^th  International Clinical Gastroenterology Conferences, December 07-08, 2017, Madrid, Spain; 13^th International Hepatology Conferences, December 07-08, 2017, Madrid, Spain; 3^rd International Colorectal Cancer Conferences, February 26-27, 2018, Paris, France; 8^th International Hepatology Conferences, July 5-7, 2018, Vienna, Austria;14^th International Gastroenterology Education Conferences, August 02-04, 2018, Barcelona, Spain; 13^th Pediatric Gastroenterology Conferences, August 02-04, 2018, Barcelona, Spain; The AASLD Liver Meetings, October 20-14, 2017, Washington DC, USA; Stockholm Liver Conferences 2018, February 6-9, 2018, Stockholm, Sweden; Canadian Digestive Diseases Conferences, February 9-12, 2018, Toronto, Canada; The 27th Asian Pacific Association for the Study of the Liver Meetings, March 14 to 18, 2018, New Delhi, India; The International Liver Meetings, April 11-15, 2018, Paris, France; 13th IHPBA World Conferences, September 3-7, 2018 Geneva, Switzerland

Related Associations:

USA and Canada:

American Hepato-Pancreato-Biliary Association; Canadian Liver Foundation; International Association for the Study of the Liver; International Hepato Pancreato Biliary Association

European Union and UK:

European Association for the Study of the Liver;  Children's Liver Disease Foundation; International Liver Transplantation Society; The European Society for Paediatric Gastroenterology Hepatology and Nutrition

Asia-Pacific and Middle East:

The Asia-Pacific Primary Liver Cancer Expert Association; The Asian Pacific Association of Gastroenterology; The Korean Association for the Study of the Liver; Asian Pacific Association for the Study of the Liver

Track 14: Gastroenterology

Gastroenterology focuses on digestive system and its disorders which include various organs from mouth to anus, along the alimentary canal. It involves a detailed understanding of the physiology of the gastrointestinal organs including the motility of food through the stomach and intestine, the digestion and absorption of nutrients into the body, removal of waste from the system, and the function of the liver as a digestive organ.

Related: Hepatitis Conferences | Liver Conferences | Gastroenterology Conferences 2018

12^th Euro-Global Gastroenterology Conferences, September 11-12, 2017 Paris, France; 2^nd Medical Imaging Conferences, September 11-12, 2017, Paris, France; 2^nd International Pancreatic Disorders, September 13-14, 2017, Dallas, USA; 13^th International Clinical Gastroenterology Conferences, November 13-14, 2017, Las Vegas, USA; 10^th International  Gastroenterology Conferences, November 13-14, 2017, Las Vegas, USA; 2^nd International  Digestive Diseases Conferences, December 07-08, 2017, Madrid, Spain; 12^th Global Gastroenterologists Meeting, March 19-20, 2018 Barcelona, Spain; 6^th World Hepatitis Conferences, June 18-20, 2018, Dublin, Ireland; 6^th World Liver Diseases Conferences, June 18-20, 2018, Dublin, Ireland; 12^th International Abdominal Imaging Conferences, June 28-29, 2018, Amsterdam, Netherlands; 12^th International Endoscopy Conferences, June 28-29, 2018, Amsterdam, Netherlands; 6^th International  Hepatology Conferences, May 28-29, 2018, Osaka, Japan; 3^rd International Pancreatic Cancer Conferences, June 11-13, 2018, Rome, Italy; 13^th  International Clinical Gastroenterology Conferences, December 07-08, 2017, Madrid, Spain; 13^th International Hepatology Conferences, December 07-08, 2017, Madrid, Spain; 3^rd International Colorectal Cancer Conferences, February 26-27, 2018, Paris, France; 8^th International Hepatology Conferences, July 5-7, 2018, Vienna, Austria;14^th International Gastroenterology Education Conferences, August 02-04, 2018, Barcelona, Spain; 13^th Pediatric Gastroenterology Conferences, August 02-04, 2018, Barcelona, Spain; The AASLD Liver Meetings, October 20-14, 2017, Washington DC, USA; Stockholm Liver Conferences 2018, February 6-9, 2018, Stockholm, Sweden; Canadian Digestive Diseases Conferences, February 9-12, 2018, Toronto, Canada; The 27th Asian Pacific Association for the Study of the Liver Meetings, March 14 to 18, 2018, New Delhi, India; The International Liver Meetings, April 11-15, 2018, Paris, France; 13th IHPBA World Conferences, September 3-7, 2018 Geneva, Switzerland

Related Associations:

USA and Canada:

American Association for the Study of Liver Diseases;  American Liver Foundation; Canadian Association of Gastroenterology; Canadian Association for the Study of the Liver; Hepatitis B Foundation; Hepatitis Foundation International

European Union and UK:

British Society of Gastroenterology; British Association for the Study of the Liver; Euroliver Foundation;  The European Liver and Intestine Transplant Association; The Belgian Association for the Study of the Liver

Asia-Pacific and Middle East:

 Gastroenterological Society of Australia; International Society for Digestive Surgery; Taiwan Liver Cancer Association; The Korean Association for the Study of the Liver

Track 15: HCV/HIV Coinfection

Overall, about one-third of people with HIV also have hepatitis C. Hepatitis C virus (HCV) can be transmitted in some of the same ways as HIV and hepatitis B. HIV can worsen hepatitis C. HIV not only increase the risk of liver damage, but it can also speed up the onset of liver damage following infection. People who are coinfected with HIV and HCV should work closely with health care providers in order to monitor and treat both conditions.

Related: Hepatitis Conferences | Liver Conferences | Gastroenterology Conferences 2018

12^th Euro-Global Gastroenterology Conferences, September 11-12, 2017 Paris, France; 2^nd Medical Imaging Conferences, September 11-12, 2017, Paris, France; 2^nd International Pancreatic Disorders, September 13-14, 2017, Dallas, USA; 13^th International Clinical Gastroenterology Conferences, November 13-14, 2017, Las Vegas, USA; 10^th International  Gastroenterology Conferences, November 13-14, 2017, Las Vegas, USA; 2^nd International  Digestive Diseases Conferences, December 07-08, 2017, Madrid, Spain; 12^th Global Gastroenterologists Meeting, March 19-20, 2018 Barcelona, Spain; 6^th World Hepatitis Conferences, June 18-20, 2018, Dublin, Ireland; 6^th World Liver Diseases Conferences, June 18-20, 2018, Dublin, Ireland; 12^th International Abdominal Imaging Conferences, June 28-29, 2018, Amsterdam, Netherlands; 12^th International Endoscopy Conferences, June 28-29, 2018, Amsterdam, Netherlands; 6^th International  Hepatology Conferences, May 28-29, 2018, Osaka, Japan; 3^rd International Pancreatic Cancer Conferences, June 11-13, 2018, Rome, Italy; 13^th  International Clinical Gastroenterology Conferences, December 07-08, 2017, Madrid, Spain; 13^th International Hepatology Conferences, December 07-08, 2017, Madrid, Spain; 3^rd International Colorectal Cancer Conferences, February 26-27, 2018, Paris, France; 8^th International Hepatology Conferences, July 5-7, 2018, Vienna, Austria;14^th International Gastroenterology Education Conferences, August 02-04, 2018, Barcelona, Spain; 13^th Pediatric Gastroenterology Conferences, August 02-04, 2018, Barcelona, Spain; The AASLD Liver Meetings, October 20-14, 2017, Washington DC, USA; Stockholm Liver Conferences 2018, February 6-9, 2018, Stockholm, Sweden; Canadian Digestive Diseases Conferences, February 9-12, 2018, Toronto, Canada; The 27th Asian Pacific Association for the Study of the Liver Meetings, March 14 to 18, 2018, New Delhi, India; The International Liver Meetings, April 11-15, 2018, Paris, France; 13th IHPBA World Conferences, September 3-7, 2018 Geneva, Switzerland

Related Associations:

USA and Canada:

American Hepato-Pancreato-Biliary Association; Canadian Liver Foundation; International Association for the Study of the Liver; International Hepato Pancreato Biliary Association; American Association for the Study of Liver Diseases

European Union and UK:

European Association for the Study of the Liver; Children's Liver Disease Foundation; International Liver Transplantation Society; The European Society for Paediatric Gastroenterology Hepatology and Nutrition

Asia-Pacific and Middle East:

The Asia-Pacific Primary Liver Cancer Expert Association; The Asian Pacific Association of Gastroenterology; Asian Pacific Association for the Study of the Liver; International Society for Digestive Surgery

Hepatitis is an inflammatory condition of the liver caused by the hepatitis virus. The most observed types of this disease are hepatitis A, hepatitis B and hepatitis C. Globally, 350 million people are chronically infected with any one form of hepatitis and around 500,000 people die every year according to World Health Organization.

Hepatitis A is a simpler form of which does not lead to chronic infections. Patients suffering from hepatitis A recover within two months as this form is less complicated and can be prevented with vaccination.

Although hepatitis B can be prevented by vaccination, once infected, a person can develop lifelong chronic infection resulting into severe liver damage. More than 2 billion people of the global population are infected with hepatitis B. Hepatitis B patients are vulnerable to further complications related to the liver, such as: hepatocellular carcinoma (liver cancer), liver failure, and liver cirrhosis.

Hepatitis C is most dangerous of among all the types of hepatitis as 80% of the hepatitis C infected patients get chronically infected. Around 150 million people are infected with hepatitis C worldwide and 350,000 people die every year. It has a cure rate of less than 80%, which drops below 60% in some regions of the world. The low cure rate is supplemented in most regions by a lack of an effective vaccine against hepatitis C. Recent estimates find that about 215,000 people in the UK are chronically infected with hepatitis C.

The global demand for Hepatitis C drug Market is expected to reach 27.63 billion USD in 2021 at a CAGR of 17% between 2016 and 2021, which was 11.81 billion USD in 2015. Key applications of hepatitis C drug market are hospitals, private labs, public health labs, blood banks and physician offices. Hepatitis C drug market can be driven by the elements like prevalence of the infection, new productive treatments, rising government subsidizing and relatively lesser time of treatment. Hepatitis C market can be influenced by treatment costs, lack of awareness and information about HCV disease.

In the United States, 20 percent to 30 percent of people living with HIV are coinfected with HCV. Hepatitis C is common among people living with HIV. This means that about 225,000 to 330,000 people in the United States are living with both viruses. The majority of people living with hepatitis C do not know they have it. The most common route of transmission in the UK is using non-sterile needles and other equipment for injecting drugs. 90 percent of people who got HIV from injecting drugs are also infected with HCV. This is because both viruses can be spread easily through blood and blood products.

HBV therapeutics market grow from $2.4 billion in 2014 to $3.0 billion in 2024 at a compound annual growth rate (CAGR) of 2.4%.

Siemens AG, MedMira Inc., Inovio Pharmaceuticals, Inc. and Abbott Laboratories are lead players involved in the development of hepatitis diagnostics.

Gilead Sciences launched couple of drugs Harvoni ((ledipasvir/sofosbuvir) and Sovaldi (sofosbuvir) in the market for Hepatitis C which captured maximum market share and has cure rate of more than 95%. In the coming years, ongoing research on hepatitis C drug development in pharmaceutical industry is expected to increase the market growth. Due to prevalence of the disease, interest for Hepatitis C medication is expanding in Africa, Middle East, Asia Pacific and Latin America.  

Liver Associations

• American Association for the Study of Liver Diseases (AASLD)
• American Gastroenterological Association
• American Hepato-Pancreato-Biliary Association (AHPBA)
• American Liver Foundation (ALF) 
• American Pancreatic Association
• American Society for Gastrointestinal Endoscopy
• Associates in Gastroenterology
• Australia and New Zealand Hepatic, Pancreatic and Biliary Association Incorporated      
• Australian Gastrointestinal Endoscopy Association  
• Asian Pacific Association for the Study of the Liver (APASL)
• British Association for the Study of the Liver (BASL)
• British Liver Trust - National charity for adult liver disease
• British Society of Gastroenterology
• Canadian Association for the Study of the Liver (CASL)
• Canadian Association of Gastroenterology
• Canadian Liver Foundation (CLF)
• Canadian Society of Gastroenterology Nurses and Associates
• Central Carolina Liver Association
• Charlottesville Gastroenterology Associates
• Childhood Liver Tumour Study Group (SIOPEL) 
• Children's Liver Disease Foundation (CLDF)
• Children's Liver Association for Support Services
• Crohn's and Colitis Foundation of America
• Euroliver Foundation
• European Association for the Study of the Liver (EASL)
• European Liver Patients Association
• European Registry of Hereditary Pancreatitis and Familial Pancreatic Cancer
• European Society of Gastroenterology and Endoscopy Nurses and Associates
• European Society of Gastrointestinal and Abdominal Radiology
• European Society of Gastrointestinal Endoscopy
• European Society of Pediatric Gastroenterology
• European Study Group of Pancreatic Cancer
• Gastroenterological Society of Australia
• Hepatitis B Foundation
• Hepatitis Foundation International          
• Hong Kong Liver Foundation
• Indian Association of Gastrointestinal Endo Surgeons
• Indian Association of Surgical Gastroenterology
• Indian Pancreas Club
• Indian Society of Gastroenterology
• Immunization Action Coalition
• International Association for the Study of the Liver (IASL)
• International Association of Pancreatology
• International Foundation for Functional Gastrointestinal Disorders
• International Hepato Pancreato Biliary Association (IHPBA)
• International Liver Transplantation Society (ILTS)
• International Liver Cancer Association
• International Society for Digestive Surgery
• Japanese Society of Gastroenterology
• Latin American Association for the Study of the Liver (ALEH)
• Liver Kids Australia
• National Pancreatic Cancer Foundation
• North American Society for Pediatric Gastroenterology, Hepatology and Nutrition
• Pancreatic Cancer Action‎
• Pancreatic Cancer Action Network
• Princeton Gastroenterology Associates
• Rappahannock Gastroenterology Associates
• Saudi Gastroenterology Association
• Society of American Gastrointestinal and Endoscopic Surgeons
• Society of Gastroenterology Nurses and Associates
• Society of Gastrointestinal Endoscopy of India
• Southern California Society of Gastroenterology
• Swiss Association for the Study of the Liver (SASL)
• Taiwan Liver Cancer Association
• Texas Society for Gastroenterology and Endoscopy
• The Asian Pacific Association of Gastroenterology
• The Asia-Pacific Primary Liver Cancer Expert Association
• The Association of Pediatric Gastroenterology and Nutrition Nurses
• The Belgian Association for the Study of the Liver
• The British Association of Paediatric Endoscopic Surgeons
• The European Association of Endoscopic Surgery
• The European Federation of Crohn's & Ulcerative Colitis Associations
• The European Liver and Intestine Transplant Association
• The European Pancreatic Club
• The European Society for Paediatric Gastroenterology Hepatology and Nutrition
• The Foundation for Liver Research
• The Hellenic Association for the Study of the Liver
• The Hepato-Pancreatico-Biliary Association of South Africa
• The Hirshberg Foundation For Pancreatic Cancer Research
• The International Association for the Study of the Liver
• The Italian Association for the Study of Pancreas
• The Korean Association for the Study of the Liver
• The National Pancreas Foundation
• The Pancreas Club
• The Pancreatic Society of Great Britain and Ireland
• The Pancreatitis Supporters Network
• The Pennsylvania Society of Gastroenterology
• The Society of Gastrointestinal Endoscopy of India
• United European Gastroenterology

Medical Colleges in Spain

• Autonomous University of Madrid
• Catholic University of Valencia San Vicente Mártir
• Complutense University of Madrid
• International University of Catalonia
• Miguel Hernández Universit
• Pompeu Fabra University
• Rovira i Virgili University
• The Autonomous University of Barcelona
• The Universitat Oberta de Catalunya (UOC) 
• The University of Barcelona (UB)
• Universidad Santiago de Compostela
• University CEU San Pablo
• University of Alcalá
• University of Alicante
• University of Cadiz
• University of Cantabria
• University of Castilla-La Mancha
• University of Cordoba
• University of Extremadura
• University of Girona
• University of Granada
• University of Jaén
• University of La Laguna
• University of Lleida
• University of Málaga
• University of Murcia
• University of Navarra
• University of Oviedo
• University of Salamanca
• University of Seville
• University of Valencia
• University of Valladolid
• University of Zaragoza

Pharmaceutical Companies in Spain

• 3P Biopharmaceuticals
• Ab Sciex Spain S.L.
• Ability Pharmaceuticals
• Accord Healthcare S.L.U.
• Actavis Spain
• Actelion Pharmaceuticals Ltd.
• Adienne
• Alcaliber
• Alcaliber SA
• Alexion Pharmaceuticals
• Allergan
• Alliance Pharmaceuticals Spain S.L
• Almirall, S.A
• Alvogen Spain SL
• Amnisure Spain S.L.
• AstraZeneca Farmaceutica Holding Spain SA
• Atos Medical Spain SL
• Baxalta Spain S.L.U.
• BCN PEPTIDES S.A
• Biofabri
• Biogen Spain, S.L
• Bioiberica S.A.
• Carestream Health Spain Sa
• Celgene Spain S.L
• Covex Farma S. L.
• Crucell Spain S A
• Cyndea Pharma S.L
• DSM Sinochem Pharmaceuticals Spain
• Esteve Química
• Farmhispania S.A.
• Farmhispania, S.A
• Ferring Pharmaceuticals
• Galenicum Health S.L
• Galenicum Health S.L.
• Geiser Pharma
• Grifols
• Grupo Ferrer Internacional
• Grupo Ferrer Internacional
• Grupo Praxis Pharmaceutical SL
• Hartington Pharmaceutical
• Hetero Europe S.L.
• I N C Research Spain S A
• Iba Molecular Spain
• Iba Molecular Spain S.A
• Idifarma Pharmaceutical Development, S. L.
• IDP Pharma
• Ipsen Pharma S.A.
• Janssen Cilag
• Kern Pharma
• Laboratorios Gebro Pharma S.A
• Laboratorios Rubio
• Laboratorios Viñas
• LEO Pharma Spain
• Lilly
• LINICAL Spain
• Medpace Spain
• Medtronic
• Mundipharma Pharmaceuticals S.L.
• Opko Health Europe
• Oryzon Genomics, S.A.
• Pfizer
• Pharma Mar SA
• Pharmaceutical Product Development Spain SL
• PharmaLex Spain S.L.U
• Praxis Pharmaceutical
• Qiagen Iberia Sl
• Qilu Pharma
• Química Sintetica S.A.
• QuintilesIMS
• Reprogenetics Spain SA
• Roche Farma
• SOM Biotech
• Spain Pharma S A
• Suanfarma, S.A.
• Sun Pharmaceuticals Spain SL
• Sweden Diagnostics Spain S L
• Synthon Hispania S.L.
• Takeda
• Teva Pharma S.L
• Tillotts Pharma Spain S L
• UltraPharma
• Uquifa
• Vegal Farmaceutica SL
• Vertex Pharmaceuticals
• Vivimed Labs Spain SL

List of Manufacturing Companies:

• AbbVie Inc.
• Bristol-Myers Squibb
• Gilead Sciences
• GlaxoSmithKline
• Janssen Pharmaceuticals
• Merck & Co.
• Merck Sharp Dohme
• Novartis
• Roche
• Schering
• Three Rivers Pharma
• Vertex Pharmaceutical

Drug Approvals and Launches:

• In 2012, the European Commission approved the use of Viread for the treatment of chronic HBV infection. Viread is also approved for the treatment of HIV infection. Patent expiration for Viread in USA is 2018 and 2017 in EU.
• In December 2013, FDA approved Sovaldi for the treatment of HCV as a component of a combination antiviral treatment regimen.
• In 2013 Janssen’s only hep c drug Olysio was approved.
• In January 2014, European Commission approved Sovaldi for the treatment of HCV. Patent expiration for Sovaldi in USA is 2029 and 2028 in EU.
• In October 2014, Gilead received FDA approval for Harvoni.
• In November 2014 Gilead received European Commission approval of Harvoni, the first once-daily single tablet regimen for the treatment of HCV genotype 1 infected patients. Patent expiration for Harvoni in USA and EU is 2030.
• In December 2014,Viekira Pak (ombitasvir/paritaprevir/ritonavir; dasabuvir) was approved by the FDA.
• In July 2015, the FDA approved AbbVie's Technivie for use in combination with ribavirin for the treatment of adults with genotype 4 HCV infection in the United States.
• In 2015 Technivie (ombitasvir/paritaprevir/ritonavir) was approved.
• In 2015, Daklinza, an NS5A inhibitor was approved.
• In January 2016, the FDA approved Zepatier for the treatment of adult patients with chronic HCV GT1 or GT4 infection, with or without ribavirin. Patent expiration for Intron A and Zepatier in USA is 2020 and 2031 respectively.
• In 2016 Viekira XR was approved which has the same components of Viekira Pak but has simpler dosing.

Drugs in Clinical development:

• Hepatitis B drugs are Direct-acting that target the virus and Indirect-acting that target the human host.

Direct-acting that target the virus is:

• ARB-1467 is currently in phase II development
• ALN-HBV is currently in preclinical trials
• Hepbarna (BB-HB-331) is currently in preclinical trials
• ARB-1740 is currently in preclinical trials
• Lunar-HBV is currently in preclinical trials

These are siRNA, nucleotide drugs that interfere with and destructs the viral RNA.

• CMX 157, a modified tenofovir drug that can get into liver cells more easily is currently in phase II development.
• Myrcludex-B (MYR GmbH): Myrcludex B, a first-in-class drug for treatment of chronic hepatitis B (HBV) and chronic hepatitis delta (HDV) infection completed Phase 2a clinical trial in chronic hepatitis B and a pilot trial in HDV infection is ongoing.
• Capsid Inhibitors that Interfere with viral capsid formation are:

• Morphothiadin (GLS4) is currently in phase II development
• NVR 3-778 is currently in phase II development
• AIC 649 is currently in phase I development
• JNJ56136379 is currently in phase I development
• HBV CpAM is in preclinical trials
• AB-423 is in preclinical trials

• HBsAg Inhibitors  that interfere with the production of Hepatitis B surface antigen are:

• Rep 2139 is currently in phase II development
• Rep 2165 is currently in phase II development
• RO7020322 (RG7834) is currently in phase I development

• Antisense Molecules that binds to the viral mRNA to prevent it from turning into a viral protein are:

• IONIS-HBVRx (GSK3228836) is currently in phase I development
• IONIS-HBVLRx (GSK33389404) is currently in phase I development

• Indirect-Acting that target human host is:

• GS 4774 is currently in phase II development
• INO-1800 is currently in phase I development
• HB-110 is currently in phase I development
• TG1050 is currently in phase I development
• HepTcell is currently in phase I development
• TomegaVax HBV is in preclinical trials

These drugs stimulate immunity as a potential therapy

• Drugs that activate the innate immune system are:

• GS 9620 is currently in Phase II development
• RO6864018 (RG7795, ANA773) is currently in phase II development
• SB9200 is currently in phase II development

• Drugs that induce programmed cell death are:

• EYP001 is currently in phase 1 development
• CRV 431 (CPI 431-32) is currently in preclinical trials

Hepatitis C drugs

• Samatasvir – currently in phase 1 development for genotypes 1, 2, 3 and 4, and in a phase II study with Olysio (simeprevir) in treatment-naïve patients with genotype 1b or 4.
• AL-335 (odalasvir) – currently in a phase IIa study for genotype 1.
• ACH-3422 and Odalasvir (ACH-3102) and Sovaprevir – currently in phase II studies in for genotype 1.
• Odalasvir plus sofosbuvir is in phase II development for genotype 1.
• Odalasvir, AL-335, and simeprevir in treatment-naive and treatment-experienced patients with and without cirrhosis for genotypes 1 through 6 are in a phase IIb study.
• GS-4997 (Gilead): GS-4997 is an ASK-1 inhibitor indicated for NASH and alcoholic hepatitis is currently under Phase II stage of development.
• GS-9674 (Gilead): GS-9674 is a FXR agonist indicated for NASH, Primary Sclerosing Cholangitis and Primary biliary cirrhosis is currently under Phase II stage of development.
• GS-0976 (Gilead): GS-0976 is an ACC Inhibitor indicated for NASH is currently under Phase II stage of development.
• 2878175 (Glaxosmithkline): 2878175 is a non-structural protein 5B (NS5B) polymerase inhibitor indicated for hepatitis C is currently under Phase I stage of clinical development.
• ARO-AAT (Arrowhead): ARO-AAT is being developed to treat the liver disease associated with alpha-1 antitrypsin deficiency. It is currently under preclinical stage of development.
• Novira therapeutics drug such as “2nd Generation Core Inhibitor” and “cccDNA” inhibitor are under discovery stage of development.
• Merck currently has two regimens in Phase II clinical trials. One regimen is called MK-3682B, or MK-3, which includes grazoprevir, ruzasvir and uprifosbuvir.

FDA approved Drugs for HBV treatment:

• Baraclude (entecavir)
• Epivir HBV (lamivudine)
• Hepsera (adefovir dipivoxil)
• Intron A (interferon alpha-2b)
• Pegasys (pegylated interferon)
• Tyzeka (telbivudine)
• Viread (tenofovir disoproxil fumarate)

FDA approved Drugs for HCV treatment:

• CoPegus (ribavirin)
• Daklinza (daclatasvir)
• Epclusa (sofosbuvir, velpatasvir)
• Harvoni (ledipasvir/sofosbuvir)
• Incivek (telaprevir)
• Infergen (interferon aphacon-1)
• Olysio (simeprevir)
• Pegintron (pegylated interferon alpha-2b)
• Rebetol (ribavirin)
• Roferon (interferon alpha-2a)
• Sovaldi (sofosbuvir)
• Technivie (ombitasvir, paritaprevir and ritonavir)
• Victrelis (boceprevir)
• Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets)
• Zepatier (elbasvir, grazoprevir)

Companies manufacturing Liver equipment’s

• Argon Medical devices Inc
• Echosens
• Humedics
• KMC Systems

FDA approved drugs in 2017

• On April 7, 2017, FDA approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to treat hepatitis C virus (HCV) in children ages 12 to 17.
• On July 18, 2017, USFDA approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis. 
• On August 3, 2017, FDA approved Mavyret, a fixed-dose combination of glecaprevir, a hepatitis C virus (HCV) NS3/4A protease inhibitor, and pibrentasvir, an HCV NS5A inhibitor.

Conference Series invites you to attend 6^th World Congress on Hepatitis and Liver diseases (Hepatitis 2018) to be held in Dublin, Ireland during June 18-20, 2018. The conference highlights the theme “Raising global awareness on screening and prevention of hepatitis”.

Conference Series organizes 300+ International Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific Societies and publishes 400+ Open Access Journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Hepatitis 2018 is a best platform with its well organized scientific program to the audience which includes symposiums, workshops, keynote lectures, plenary talks, panel discussions and poster sessions on latest research and technological developments in the arena as well as therapeutic aspects. The conference invites Hepatologists, Gastroenterologists, Virologists, Microbiologists, Pathologists, Oncologists, Toxicologists, Researchers, Students, Young researchers and business delegates across the globe.

Scope of the Conference

Hepatitis 2018 provides a great platform by gathering eminent professors, Researchers, Students and delegates to exchange new ideas.  The conference will cover a wide range of topics and allow participants to discuss about the management of liver diseases. Hepatitis 2018 conference consists of keynote and plenary lectures, special sessions (Workshop and Symposium), Young Researcher Forum and Poster presentations. Best poster presenters will be judged and awarded during the conference. To encourage broad participation from all over the world Conference Series Ltd is offering reduced registration fee for students.

Conference Opportunities

For Researchers and Faculty Members:

Speaker Presentations
Poster Display
Symposium hosting (4-5 member team)
Workshop organizing

For Universities, Associations & Societies:

Association Partnering
Collaboration proposals
Academic Partnering
Group Participation

For Students and Research Scholars:

Poster Competition (Winner will get Best Poster Award)
Young Researcher Forum (YRF Award to the best presenter)
Student Attendee
Group registrations

For Business Delegates:

Speaker Presentations
Symposium hosting
Networking opportunities

For Product Manufacturers: